Peter R. Carroll
0000-0002-1086-4334
Publication & Citation Trends
Publications
0 total
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer.
Cited by 0
Semantic Scholar
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.
Cited by 2
Semantic Scholar
PD10-03 DETERMINING THE ROLE OF THE TUMOR MICROENVIRONMENT SECRETOME ON RESPONSE TO PHOSPHOINOSITIDE 3-KINASE PATHWAY INHIBITION IN PROSTATE CANCER
Cited by 0
Semantic Scholar
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era.
Cited by 3
Semantic Scholar
Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients.
Cited by 0
Semantic Scholar
P502 – Determining optimal patient selection for High-Intensity Focused Ultrasound (HIFU) for prostate cancer: Results from a single-institution cohort
Cited by 0
Semantic Scholar
MP39-18 TIMING OF RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR MEN WITH HIGH RISK DISEASE
Cited by 0
Semantic Scholar
DOES GENOMIC RISK SCORE AT BIOPSY CORRELATE WITH FOCALITY OF DISEASE AT RADICAL PROSTATECTOMY: IMPLICATIONS FOR FOCAL THERAPY CANDIDATES
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Diagnosis and Treatment
(814)
Prostate Cancer Treatment and Research
(773)
Bladder and Urothelial Cancer Treatments
(238)
Urologic and reproductive health conditions
(121)
Cancer, Lipids, and Metabolism
(73)
Affiliations
Kanazawa University
Kagoshima University
University of Iowa
Fairfield University
Brigham and Women's Hospital